Literature DB >> 28566961

Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder.

İpek Sönmez1, Ferdi Köşger2, Ümit Aykan3.   

Abstract

INTRODUCTION: In recent years, an increasing number of studies have researched retinal nerve fiber layer (RNFL) changes in neurodegenerative disorders. In this study, our aim was to determine structural RNFL changes in patients with major depressive disorder.
METHODS: A total of 30 patients with major depressive disorder and 30 age- and sex-matched controls were recruited. Using optical coherence tomography (OCT), the peripapillary RNFL thickness in major depressive disorder patients and control subjects was measured and compared at each location.
RESULTS: Patients with major depressive disorder did not show a statistically significant reduction in overall peripapillary RNFL thickness.
CONCLUSION: Our study showed that RNFL thickness is not reduced in major depressive disorder patients and that OCT is not a useful tool for diagnosing and monitoring the progression of major depressive disorder. This study suggests that the pathophysiology of unipolar depression is different than in neurodegenerative disorders, pervasive developmental disorders, schizophrenia, and bipolar disorder.

Entities:  

Keywords:  Depression; magnocellular pathway; retina

Year:  2017        PMID: 28566961      PMCID: PMC5439474          DOI: 10.5152/npa.2015.10115

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  41 in total

1.  Abnormalities in color vision and contrast sensitivity in Parkinson's disease.

Authors:  M J Price; R G Feldman; D Adelberg; H Kayne
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

2.  Association of cognitive functioning with retinal nerve fiber layer thickness.

Authors:  Leonieke M E van Koolwijk; Dominiek D G Despriet; Cornelia M Van Duijn; Ben A Oostra; John C van Swieten; Inge de Koning; Caroline C W Klaver; Hans G Lemij
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

3.  Backward masking in schizophrenia: relationship to medication status, neuropsychological functioning, and dopamine metabolism.

Authors:  P D Butler; J M Harkavy-Friedman; X F Amador; J M Gorman
Journal:  Biol Psychiatry       Date:  1996-08-15       Impact factor: 13.382

4.  Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.

Authors:  Roy H Perlis; Jordan W Smoller; Jayalakshmi Mysore; Mei Sun; Tammy Gillis; Shaun Purcell; Marcella Rietschel; Markus M Nöthen; Stephanie Witt; Wolfgang Maier; Dan V Iosifescu; Patrick Sullivan; A John Rush; Maurizio Fava; Hans Breiter; Marcy Macdonald; James Gusella
Journal:  Am J Psychiatry       Date:  2010-04-01       Impact factor: 18.112

5.  Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder.

Authors:  Kebreten F Manaye; D-Liang Lei; Yousef Tizabi; Martha I Dávila-García; Peter R Mouton; Peter H Kelly
Journal:  J Neuropathol Exp Neurol       Date:  2005-03       Impact factor: 3.685

6.  White matter lesions and temporal lobe atrophy related to incidence of both dementia and major depression in 70-year-olds followed over 10 years.

Authors:  P Gudmundsson; P J Olesen; M Simoni; L Pantoni; S Östling; S Kern; X Guo; I Skoog
Journal:  Eur J Neurol       Date:  2015-01-18       Impact factor: 6.089

Review 7.  Evidence for an immune response in major depression: a review and hypothesis.

Authors:  M Maes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

8.  Impaired recognition of social emotions following amygdala damage.

Authors:  Ralph Adolphs; Simon Baron-Cohen; Daniel Tranel
Journal:  J Cogn Neurosci       Date:  2002-11-15       Impact factor: 3.225

9.  S100B is increased in mood disorders and may be reduced by antidepressive treatment.

Authors:  Matthias L Schroeter; Hashim Abdul-Khaliq; Albert Diefenbacher; Ingolf E Blasig
Journal:  Neuroreport       Date:  2002-09-16       Impact factor: 1.837

Review 10.  Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?

Authors:  Kin Chiu; Tin-Fung Chan; Andrew Wu; Irene Yan-Pui Leung; Kwok-Fai So; Raymond Chuen-Chung Chang
Journal:  Age (Dordr)       Date:  2011-05-11
View more
  5 in total

1.  Ocular and Hemodynamic Factors Contributing to the Central Visual Function in Glaucoma Patients With Myopia.

Authors:  Kyung Euy Hong; Seong Ah Kim; Da-Young Shin; Chan Kee Park; Hae-Young Lopilly Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

2.  Ability of swept source OCT to detect retinal changes in patients with bipolar disorder.

Authors:  Vicente Polo; Maria Satue; Alicia Gavin; Elisa Vilades; Elvira Orduna; Marta Cipres; Javier Garcia-Campayo; Mayte Navarro-Gil; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin
Journal:  Eye (Lond)       Date:  2018-10-31       Impact factor: 3.775

3.  The Place of Optical Coherence Tomography in Patients with Obsessive Compulsive Disorder.

Authors:  Selim Polat; Berrak Sekeryapan Gediz; Alaattin Cenk Ercan; Muhammet Kaim; Cicek Hocaoglu
Journal:  Eurasian J Med       Date:  2019-10

4.  Association of Retinal Nerve Fiber Layer Thickness, an Index of Neurodegeneration, With Depressive Symptoms Over Time.

Authors:  Frank C T van der Heide; Indra L M Steens; Anouk F J Geraets; Yuri D Foreman; Ronald M A Henry; Abraham A Kroon; Carla J H van der Kallen; Thomas T van Sloten; Pieter C Dagnelie; Martien C J M van Dongen; Simone J P M Eussen; Tos T J M Berendschot; Jan S A G Schouten; Carroll A B Webers; Marleen M J van Greevenbroek; Anke Wesselius; Annemarie Koster; Nicolaas C Schaper; Miranda T Schram; Seb Köhler; Coen D A Stehouwer
Journal:  JAMA Netw Open       Date:  2021-11-01

5.  Portable light therapy in the treatment of unipolar non-seasonal major depressive disorder: study protocol for the LUMIDEP randomised controlled trial.

Authors:  Eve Cosker; Marie Moulard; Samuel Schmitt; Karine Angioi-Duprez; Cédric Baumann; Vincent Laprévote; Raymund Schwan; Thomas Schwitzer
Journal:  BMJ Open       Date:  2021-07-09       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.